Skip to Content

Proteonomix Inc

Rating as of

Company Profile

Business Description

Proteonomix Inc develops pre-clinical-stage therapeutic agents and treatments for diabetes, heart, and lung diseases. The company focuses on developing therapeutics based upon the use of human cells and their derivative.

140 East Ridgewood Avenue, Suite 415
Paramus, NJ, 07652
T +1 973 949-4195
Sector Healthcare
Industry Biotechnology
Most Recent Earnings Jun 30, 2012
Fiscal Year End Dec 31, 2012
Stock Type Distressed
Employees 2